Skip to main content
. 2022 Aug 1;25(2):351–364. doi: 10.1093/neuonc/noac185

Table 1.

Participant Characteristics of the Cohort Over Time (T1, T2, T3)

Full Cohort
T1 (N = 195)
First Follow-up
T2 (N = 65)
Current Follow-up
T3 (N = 30)
Age in years M (SD), range 40.8 (11.6), 18–70 44.5 (12.1), 23–72 52.33 (11.52), 36–72
Age at diagnosis M (SD), range 34.3 (12.5), 8–65 32.0 (13.6), 8–62 25.97 (12.44), 8–50
Sex, N(%) Male 120 (61.5) 36 (55.4) 15 (50.0)
Female 75 (38.5) 29 (44.6) 15 (50.0)
Level of education, N(%) Low 58 (29.7) 21 (32.3) 5 (16.7)
Middle 74 (37.9) 22 (33.8) 11 (36.7)
High 60 (30.8) 22 (33/8) 13 (43.3)
Other 3 (1.5) 0 (0) 1 (3.3)
Marital status, N(%) Single 56 (28.7) 17 (26.2) 6 (20.0)
Married or living together 124 (63.6) 38 (58.5) 20 (66.7)
Divorced 6 (3.1) 7 (10.8) 2 (6.7)
Widowed 6 (3.1) 3 (4.6) 2 (6.7)
Missing 3 (1.5) 0 (0) 0 (0)
Tumor type, N(%) Astrocytoma 127 (65.1) 47 (72.3) 25 (83.3)
Oligoastrocytoma 12 (6.2) 7 (10.7) 2 (6.7)
Oligodendroglioma 39 (20.0) 11 (16.9) 3 (10.0)
Missing 17 (8.7) 0 (0) 0 (0)
WHO tumor grade, N(%) I 11 (5.6) 7 (10.8) 0 (0)
II 163 (83.6) 57 (87.7) 30 (100)
Missing 21 (10.8) 1 (1.5) 0 (0)
Neurosurgical intervention, N(%) Biopsy 71 (36.4) 19 (29.2) 7 (23.3)
Resection 94 (48.2) 41 (63.1) 20 (66.7)
Craniotomy, unspecified 12 (6.2) 5 (7.7) 3 (10.0)
Missing 18 (9.2) 0 (0) 0 (0)
Radiotherapy (ever), N (%) Yes 104 (53.3) 32 (49.0) 13 (43.3)
No 91 (46.7) 33 (51.0) 17 (56.7)
Recurrence (ever), N (%) Yes 19 (9.7) 0 (0) 6 (20.0)
No 154 (79.0) 65 (100) 23 (76.7)
Missing 19 (9.7) 0 (0) 1 (3.3)